Below is a list of upcoming stem cell and regenerative medicine conferences and meetings for 2016. You can see the meeting list for 2020 here. The new year has a lot to offer in our field. If you do not see your meeting, please let me know and I will include it. This list is […]
2016 Stem Cell & Regenerative Medicine Meetings Read More »
In 2014, I reported on a groundbreaking, but debated Duke stem cell-based clinical trial being launched for autism. Where does that trial stand today? (note that as of 2018-2020 I am very skeptical about stem cells for autism) The cord blood trial has continued. It is led by Dr. Joanne Kurtzberg, whom I interviewed about cord blood stem
Upbeat Update from Duke on Stem Cell Autism Trial, but Questions Remain Read More »
I just got back from a historic summit on human genetic modification in Washington, D.C. New genetic modification technology, termed CRISPR-Cas9, has both made genetic modification a relatively simple matter for scientists and human genetic modification much more likely in the near future. Heritable human genetic modification could prevent some rare genetic diseases so there
How do governance issues for human genome editing work at the international level? Indira Nath, All India Institute of Medical Sciences, gives a nice overview to start the session. She raised the example of medical tourism and surrogacy in India. She argued for an international consensus on what is permissible on human gene editing. How
Live Blog #GeneEditSummit Day 2 Post #2: International Governance Read More »
Now we have an interesting panel starting on questions of governance on human gene editing. This will focus on institutional and national levels of governance. Pilar N. Ossorio, University of Wisconsin, Madison, and Morgridge Institute for Research, is introducing the panel. Key question: how should emerging technologies being governed? Jonathan Kimmelman, from McGill, was the first
Live Blogging #GeneEditSummit Day 2 Post #1: Governance of human gene editing Read More »
The post-lunch session is “Applications of Gene Editing Technology: Human Germline Modification”. Prior to hearing it I’m curious how cautious or gung-ho the speakers will be, or if their gestalt will be one of balance in the middle somewhere. Robin Lovell-Badge, The Francis Crick Institute, was the moderator of this session. He said, “We’d be
Live Blogging #GeneEditSummit Day 1 Post #3: human germline modification Read More »
Now we hear from the scientists on the front lines of CRISPR, covered in this post #2 of the Human Gene Editing Meeting. You can read Post #1 here. Jennifer Doudna starts off the big human gene editing science session on the current state of the human gene editing science and CRISPR. She gave an
Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR Read More »
Congratulations to Dr. Jeanne Loring, the winner of the Stem Cell Person of the Year Award for 2015. Facing steep competition from a very tough field of competitors of finalists, Jeanne came out as the winner for her exceptional contributions in 2015 and throughout her many years in the field. She not only has made
Stem Cell Person of the Year 2015: Jeanne Loring Read More »
By Heather Main I was a little ashamed of myself that I didn’t know who half of the finalists were in Paul Knoepfler’s Stem Cell Person of the Year Award. I decided to look into it and find out what (or who) I have missed…..Interestingly, 3 of the 7 listed here are not scientists but
Mini-bios on finalists for Stem Cell Person of the Year Read More »
By Jeanne Loring Last Tuesday I visited the FDA headquarters in Maryland, for a meeting called Public Meeting on Patient-Focused Drug Development for Huntington’s and Parkinson’s Diseases. The FDA holds about 6 meetings on different diseases each year, inviting patients and advocates to speak while a panel of FDA directors listens. The FDA representatives at
Guest Post from Jeanne Loring: Patients talk stem cells. The FDA listens. Read More »